Ben Ho Park, MD, PhD, said the deep knowledge and experience of the pair will optimize and personalize the prevention, diagnosis and treatment of GI malignancies.

Together, the co-leaders bring complementary expertise aimed at delivering the most innovative and advanced options for patients at all stages of lung and other thoracic cancers.

The urine test offers a noninvasive option to determine which patients truly need to undergo a biopsy and which can avoid a potentially unnecessary and invasive procedure.

This minimally invasive and cost-effective alternative to tissue biopsy offers “an accessible tool for tailoring treatment strategies in breast cancer,” researchers reported April 22 in the journal Science Translational Medicine.

These findings highlight the critical need for tumor genomic testing for all patients to identify those with high-risk tumors, which occur more frequently in Black women, and which require more aggressive treatment to prevent recurrence.

Oncologist Mohamed Shanshal, MD, said robotic bronchoscopy significantly improves getting patients the appropriate treatment as soon as possible, reducing their anxiety and improving care.

These findings shed light on disruptions in normal blood cell development (hematopoiesis) that may be shared by sickle cell disease and clonal hematopoiesis.